Day One Biopharmaceuticals Inc - DAWN - stock price prediction, stock price target, analyst ratings from 10 analysts

Day One Biopharmaceuticals Inc has a share price target of US$ 24, revenue growth forecast of 10.8%, and profit growth estimate of -32.2% for FY25, based on top 10 analyst calls.